Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Manfred Schwab

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Physiology

Genes & Molecular Sequences

Anatomy

Procedures

Chemicals & Drugs

Living Beings

Mice

Concepts & Ideas

Molecular Sequence Data

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Eckerle Isabella; Muth Daniel; Batzler Julia; Henrich Kai-Oliver; Lutz Werner; Fischer Matthias; Witt Olaf; Schwab Manfred; Westermann Frank
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma.
Theissen Jessica; Boensch Marc; Spitz Ruediger; Betts David; Stegmaier Sabine; Christiansen Holger; Niggli Felix; Schilling Freimut; Schwab Manfred; Simon Thorsten; Westermann Frank; Berthold Frank; Hero Barbara
Heterogeneity of the MYCN oncogene in neuroblastoma.
Praml Christian; Schulz Wolfgang; Claas Andreas; Mollenhauer Jan; Poustka Annemarie; Ackermann Rolf; Schwab Manfred; Henrich Kai-Oliver
Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Manfred Schwab (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Eckerle Isabella; Muth Daniel; Batzler Julia; Henrich Kai-Oliver; Lutz Werner; Fischer Matthias; Witt Olaf; Schwab Manfred; Westermann Frank
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma.
Cancer letters 2009;285(1):99-107.
2009: Theissen Jessica; Boensch Marc; Spitz Ruediger; Betts David; Stegmaier Sabine; Christiansen Holger; Niggli Felix; Schilling Freimut; Schwab Manfred; Simon Thorsten; Westermann Frank; Berthold Frank; Hero Barbara
Heterogeneity of the MYCN oncogene in neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2085-90.
2008: Praml Christian; Schulz Wolfgang; Claas Andreas; Mollenhauer Jan; Poustka Annemarie; Ackermann Rolf; Schwab Manfred; Henrich Kai-Oliver
Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells.
Cancer letters 2008;272(1):160-6.
2008: Sagulenko Vitalia; Muth Daniel; Sagulenko Evgeny; Paffhausen Tobias; Schwab Manfred; Westermann Frank
Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death.
Carcinogenesis 2008;29(10):1869-77.
2008: Deubzer Hedwig E; Ehemann Volker; Kulozik Andreas E; Westermann Frank; Savelyeva Larissa; Kopp-Schneider Annette; Riester Daniel; Schwab Manfred; Witt Olaf
Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro.
Cancer letters 2008;264(1):21-8.
2008: Deubzer Hedwig E; Ehemann Volker; Westermann Frank; Heinrich Ralf; Mechtersheimer Gunhild; Kulozik Andreas E; Schwab Manfred; Witt Olaf
Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cells.
International journal of cancer. Journal international du cancer 2008;122(8):1891-900.
2007: Sagulenko Evgeny; Savelyeva Larissa; Ehemann Volker; Sagulenko Vitaliya; Hofmann Wera; Arnold Katrin; Claas Andreas; Scherneck Siegfried; Schwab Manfred
Suppression of polyploidy by the BRCA2 protein.
Cancer letters 2007;257(1):65-72.
2007: Sawinska Malgorzata; Schmitt Jens Guido; Sagulenko Evgeny; Westermann Frank; Schwab Manfred; Savelyeva Larissa
Novel aphidicolin-inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene.
Genes, chromosomes & cancer 2007;46(11):991-9.
2007: Westermann Frank; Henrich Kai-Oliver; Wei Jun S; Lutz Werner; Fischer Matthias; König Rainer; Wiedemeyer Ruprecht; Ehemann Volker; Brors Benedikt; Ernestus Karen; Leuschner Ivo; Benner Axel; Khan Javed; Schwab Manfred
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(16):4695-703.
2007: Fechter Anne; Buettel Isabel; Kuehnel Elisabeth; Schwab Manfred; Savelyeva Larissa
Cloning of genetically tagged chromosome break sequences reveals new fragile sites at 6p21 and 13q22.
International journal of cancer. Journal international du cancer 2007;120(11):2359-67.
2007: Oberthuer André; Warnat Patrick; Kahlert Yvonne; Westermann Frank; Spitz Rüdiger; Brors Benedikt; Hero Barbara; Eils Roland; Schwab Manfred; Berthold Frank; Fischer Matthias
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.
Cancer letters 2007;250(2):250-67.
2007: Paffhausen Tobias; Schwab Manfred; Westermann Frank
Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells.
Cancer letters 2007;250(1):17-24.
2007: Henrich Kai-Oliver; Claas Andreas; Praml Christian; Benner Axel; Mollenhauer Jan; Poustka Annemarie; Schwab Manfred; Westermann Frank
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma.
European journal of cancer (Oxford, England : 1990) 2007;43(3):607-16.
2007: Hormozian Fabiola; Schmitt Jens Guido; Sagulenko Evgeny; Schwab Manfred; Savelyeva Larissa
FRA1E common fragile site breaks map within a 370kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD).
Cancer letters 2007;246(1-2):82-91.
2007: Suspitsin Evgeny N; Sokolenko Anna P; Togo Alexandr V; Lazareva Yulia R; Turkevich Elena A; Matsko Dmitry E; Henrich Kai-Oliver; Borresen-Dale Anne-Lise; Schwab Manfred; Cornelisse Cees J; Imyanitov Evgeny N
Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias.
International journal of cancer. Journal international du cancer 2007;120(2):297-302.
2007: Fechter Anne; Buettel Isabel; Kuehnel Elisabeth; Savelyeva Larissa; Schwab Manfred
Common fragile site FRA11G and rare fragile site FRA11B at 11q23.3 encompass distinct genomic regions.
Genes, chromosomes & cancer 2007;46(1):98-106.
2006: Oberthuer André; Berthold Frank; Warnat Patrick; Hero Barbara; Kahlert Yvonne; Spitz Rüdiger; Ernestus Karen; König Rainer; Haas Stefan; Eils Roland; Schwab Manfred; Brors Benedikt; Westermann Frank; Fischer Matthias
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):5070-8.
2006: Chen Qing-Rong; Bilke Sven; Wei Jun S; Greer Braden T; Steinberg Seth M; Westermann Frank; Schwab Manfred; Khan Javed
Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma.
Genes, chromosomes & cancer 2006;45(9):856-62.
2006: Askoxylakis Vasileios; Mier Walter; Zitzmann Sabine; Ehemann Volker; Zhang Jianbing; Krämer Susanne; Beck Carmen; Schwab Manfred; Eisenhut Michael; Haberkorn Uwe
Characterization and development of a peptide (p160) with affinity for neuroblastoma cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):981-8.
2006: Henrich Kai-Oliver; Fischer Matthias; Mertens Daniel; Benner Axel; Wiedemeyer Ruprecht; Brors Benedikt; Oberthuer André; Berthold Frank; Wei Jun Stephen; Khan Javed; Schwab Manfred; Westermann Frank
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(1):131-8.
2006: Savelyeva Larissa; Sagulenko Evgeny; Schmitt Jens Guido; Schwab Manfred
Low-frequency common fragile sites: link to neuropsychiatric disorders?
Cancer letters 2006;232(1):58-69.
2006: Savelyeva Larissa; Sagulenko Evgeny; Schmitt Jens Guido; Schwab Manfred
The neurobeachin gene spans the common fragile site FRA13A.
Human genetics 2006;118(5):551-8.
2005: Bilke Sven; Chen Qing-Rong; Westerman Frank; Schwab Manfred; Catchpoole Daniel; Khan Javed
Inferring a tumor progression model for neuroblastoma from genomic data.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(29):7322-31.
2005: Askoxylakis Vasileios; Zitzmann Sabine; Mier Walter; Graham Keith; Krämer Susanne; von Wegner Frederic; Fink Rainer H A; Schwab Manfred; Eisenhut Michael; Haberkorn Uwe
Preclinical evaluation of the breast cancer cell-binding peptide, p160.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6705-12.
2004: Büttel Isabel; Fechter Anne; Schwab Manfred
Common fragile sites and cancer: targeted cloning by insertional mutagenesis.
Annals of the New York Academy of Sciences 2004;1028():14-27.
2004: Wei Jun S; Greer Braden T; Westermann Frank; Steinberg Seth M; Son Chang-Gue; Chen Qing-Rong; Whiteford Craig C; Bilke Sven; Krasnoselsky Alexei L; Cenacchi Nicola; Catchpoole Daniel; Berthold Frank; Schwab Manfred; Khan Javed
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma.
Cancer research 2004;64(19):6883-91.
2004: Chen Qing-Rong; Bilke Sven; Wei Jun S; Whiteford Craig C; Cenacchi Nicola; Krasnoselsky Alexei L; Greer Braden T; Son Chang-Gue; Westermann Frank; Berthold Frank; Schwab Manfred; Catchpoole Daniel; Khan Javed
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.
BMC genomics 2004;5(1):70.
2004: Kim Min-Kyoung; Zitzmann Sabine; Westermann Frank; Arnold Katrin; Brouwers Stefan; Schwab Manfred; Savelyeva Larissa
Increased rates of spontaneous sister chromatid exchange in lymphocytes of BRCA2+/- carriers of familial breast cancer clusters.
Cancer letters 2004;210(1):85-94.
2004: Schwab Manfred
MYCN in neuronal tumours.
Cancer letters 2004;204(2):179-87.
2003: Wittke Isabel; Wiedemeyer Ruprecht; Pillmann Andrea; Savelyeva Larissa; Westermann Frank; Schwab Manfred
Neuroblastoma-derived sulfhydryl oxidase, a new member of the sulfhydryl oxidase/Quiescin6 family, regulates sensitization to interferon gamma-induced cell death in human neuroblastoma cells.
Cancer research 2003;63(22):7742-52.
2003: Schwab Manfred; Westermann Frank; Hero Barbara; Berthold Frank
Neuroblastoma: biology and molecular and chromosomal pathology.
The lancet oncology 2003;4(8):472-80.
2003: Praml Christian; Savelyeva Larissa; Schwab Manfred
Aflatoxin B1 aldehyde reductase (AFAR) genes cluster at 1p35-1p36.1 in a region frequently altered in human tumour cells.
Oncogene 2003;22(30):4765-73.
2003: Mädge Britta; Geisen Christoph; Möröy Tarik; Schwab Manfred
Yaf2 inhibits Myc biological function.
Cancer letters 2003;193(2):171-6.
2003: Wiedemeyer Ruprecht; Westermann Frank; Wittke Isabel; Nowock Joachim; Schwab Manfred
Ataxin-2 promotes apoptosis of human neuroblastoma cells.
Oncogene 2003;22(3):401-11.
2003: Matzner Isabel; Savelyeva Larissa; Schwab Manfred
Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line.
Cancer letters 2003;189(2):207-19.
2002: Berwanger Bernd; Hartmann Oliver; Bergmann Eckhard; Bernard Sandra; Nielsen Dirk; Krause Michael; Kartal Ali; Flynn Daniel; Wiedemeyer Ruprecht; Schwab Manfred; Schäfer Helmut; Christiansen Holger; Eilers Martin
Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma.
Cancer cell 2002;2(5):377-86.
2002: Westermann Frank; Schwab Manfred
Genetic parameters of neuroblastomas.
Cancer letters 2002;184(2):127-47.
2002: Zitzmann Sabine; Ehemann Volker; Schwab Manfred
Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo.
Cancer research 2002;62(18):5139-43.
2002: Schwab Manfred
Amplified MYCN in human neuroblastoma: paradigm for the translation of molecular genetics to clinical oncology.
Annals of the New York Academy of Sciences 2002;963():63-73.
2002: Schwab Manfred; Claas Andreas; Savelyeva Larissa
BRCA2: a genetic risk factor for breast cancer.
Cancer letters 2002;175(1):1-8.
2001: Zhang J; Spring H; Schwab M
Neuroblastoma tumor cell-binding peptides identified through random peptide phage display.
Cancer letters 2001;171(2):153-64.
2001: Bannasch D; Mädge B; Schwab M
Functional interaction of Yaf2 with the central region of MycN.
Oncogene 2001;20(41):5913-9.
2001: Savelyeva L; Claas A; Matzner I; Schlag P; Hofmann W; Scherneck S; Weber B; Schwab M
Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers.
Cancer research 2001;61(13):5179-85.
2001: Bauer A; Savelyeva L; Claas A; Praml C; Berthold F; Schwab M
Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig.
Genes, chromosomes & cancer 2001;31(3):228-39.
2001: Savelyeva L; Schwab M
Amplification of oncogenes revisited: from expression profiling to clinical application.
Cancer letters 2001;167(2):115-23.
2001: Würfel J; Seiter S; Stassar M; Claas A; Kläs R; Rösel M; Marhaba R; Savelyeva L; Schwab M; Matzku S; Zöller M
Cloning of the human homologue of the metastasis-associated rat C4.4A.
Gene 2001;262(1-2):35-41.
2001: Wittke I; Mädge B; Wiedemeyer R; Kimchi A; Schwab M
DAP-5 is involved in MycN/IFNgamma-induced apoptosis in human neuroblastoma cells.
Cancer letters 2001;162(2):237-43.
2001: Claas A; Savelyeva L; Pillmann A; Schwab M
Chromosomal mapping of human genes by radioactive hybridization of cDNAs to CEPH-YAC high density gridded filter sets.
Cancer letters 2001;162(1):125-31.
2000: Claas A; Savelyeva L; Pillmann A; Schwab M
Chromosomal mapping of human genes by radioactive hybridization of cDNAs to Centre d'Etude du Polymorphisme humain high density gridded filter sets.
Cancer letters 2000;156(1):19-25.
2000: Amler L C; Bauer A; Corvi R; Dihlmann S; Praml C; Cavenee W K; Schwab M; Hampton G M
Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.
Genomics 2000;64(2):195-202.
1999: Bannasch D; Weis I; Schwab M
Nmi protein interacts with regions that differ between MycN and Myc and is localized in the cytoplasm of neuroblastoma cells in contrast to nuclear MycN.
Oncogene 1999;18(48):6810-7.
1999: Bannasch D; Schwab M
A versatile bait vector allowing rapid isolation of prey vectors in Gal4-dependent yeast two-hybrid screens.
Plasmid 1999;42(2):139-43.
1999: An H X; Claas A; Savelyeva L; Seitz S; Schlag P; Scherneck S; Schwab M
Two regions of deletion in 9p23-24 in sporadic breast cancer.
Cancer research 1999;59(16):3941-3.
1999: Schwab M
Oncogene amplification in solid tumors.
Seminars in cancer biology 1999;9(4):319-25.
1999: Schwab M
Human neuroblastoma: from basic science to clinical debut of cellular oncogenes.
Die Naturwissenschaften 1999;86(2):71-8.
1999: Savelyeva L; Claas A; An H; Weber R G; Lichter P; Schwab M
Retention of polysomy at 9p23-24 during karyotypic evolution in human breast cancer cell line COLO 824.
Genes, chromosomes & cancer 1999;24(1):87-93.
1999: Perri P; Praml C; Savelyeva L; Pillmann A; Schwab M
Fine mapping of distal 1p loci reveals TP73 at D1S468.
Cytogenetics and cell genetics 1999;84(1-2):111-4.
1999: Schwab M
From fish to FISH: the comparative pathology of neuroblastomas in humans, mice and fish.
Journal of cancer research and clinical oncology 1999;125(3-4):141-9.
1998: Praml C; Savelyeva L; Perri P; Schwab M
Cloning of the human aflatoxin B1-aldehyde reductase gene at 1p35-1p36.1 in a region frequently altered in human tumor cells.
Cancer research 1998;58(22):5014-8.
1998: Praml C; Amler L C; Dihlmann S; Finke L H; Schlag P; Schwab M
Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa.
Oncogene 1998;17(15):2009-12.
1998: Lutz W; Fulda S; Jeremias I; Debatin K M; Schwab M
MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells.
Oncogene 1998;17(3):339-46.
1998: Schwab M
Amplification of oncogenes in human cancer cells.
BioEssays : news and reviews in molecular, cellular and developmental biology 1998;20(6):473-9.
1998: Claas C; Seiter S; Claas A; Savelyeva L; Schwab M; Zöller M
Association between the rat homologue of CO-029, a metastasis-associated tetraspanin molecule and consumption coagulopathy.
The Journal of cell biology 1998;141(1):267-80.
1998: Savelyeva L; Claas A; Gier S; Schlag P; Finke L; Mangion J; Stratton M R; Schwab M
An interstitial tandem duplication of 9p23-24 coexists with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer.
Cancer research 1998;58(5):863-6.
1997: Berthold F; Sahin K; Hero B; Christiansen H; Gehring M; Harms D; Horz S; Lampert F; Schwab M; Terpe J
The current contribution of molecular factors to risk estimation in neuroblastoma patients.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2092-7.
1997: Lutz W; Schwab M
In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Oncogene 1997;15(3):303-15.
1997: Dihlmann S; Amler L C; Schwab M; Wenzel A
Variations in the expression of the adenomatous polyposis coli (APC) tumor suppressor gene in human cancer cell lines of different tissue origin.
Oncology research 1997;9(3):119-27.
1996: Schwab M; Praml C; Amler L C
Genomic instability in 1p and human malignancies.
Genes, chromosomes & cancer 1996;16(4):211-29.
1996: Lutz W; Stöhr M; Schürmann J; Wenzel A; Löhr A; Schwab M
Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells.
Oncogene 1996;13(4):803-12.
1996: Amler L C; Schürmann J; Schwab M
The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
Genes, chromosomes & cancer 1996;15(2):134-7.
1995: Praml C; Savelyeva L; Le Paslier D; Siracusa L D; Buchberg A M; Schwab M; Amler L C
Human homologue of a candidate for the Mom1 locus, the secretory type II phospholipase A2 (PLA2S-II), maps to 1p35-36.1/D1S199.
Cancer research 1995;55(23):5504-6.
1995: Gehring M; Berthold F; Edler L; Schwab M; Amler L C
The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
Cancer research 1995;55(22):5366-9.
1995: Praml C; Finke L H; Herfarth C; Schlag P; Schwab M; Amler L
Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer.
Oncogene 1995;11(7):1357-62.
1995: Corvi R; Savelyeva L; Schwab M
Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.
Cancer research 1995;55(16):3471-4.
1995: Amler L C; Corvi R; Praml C; Savelyeva L; Le Paslier D; Schwab M
A reciprocal translocation (1;15) (36.2;q24) in a neuroblastoma cell line is accompanied by DNA duplication and may signal the site of a putative tumor suppressor-gene.
Oncogene 1995;10(6):1095-101.
1995: Corvi R; Savelyeva L; Breit S; Wenzel A; Handgretinger R; Barak J; Oren M; Amler L; Schwab M
Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma.
Oncogene 1995;10(6):1081-6.
1995: Amler L C; Corvi R; Praml C; Savelyeva L; Le Paslier D; Schwab M
Reciprocal translocation at 1p36.2/D1S160 in a neuroblastoma cell line: isolation of a YAC clone at the break.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):527-30.
1995: Corvi R; Savelyeva L; Amler L; Handgretinger R; Schwab M
Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):520-3.
1995: Wenzel A; Schwab M
The mycN/max protein complex in neuroblastoma. Short review.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):516-9.
1994: Savelyeva L; Corvi R; Schwab M
Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells.
American journal of human genetics 1994;55(2):334-40.
1994: Corvi R; Amler L C; Savelyeva L; Gehring M; Schwab M
MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(12):5523-7.
1994: Schwab M
Human neuroblastoma: amplification of the N-myc oncogene and loss of a putative cancer-preventing gene on chromosome 1p.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1994;135():7-16.
1994: Wenzel A; Cziepluch C; Schürmann J; Schwab M
The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.
Progress in clinical and biological research 1994;385():59-66.
1994: Schwab M
Where pathology meets molecular biology: N-myc amplification in human neuroblastoma as a paradigm for the clinical use of an oncogene alteration.
Verhandlungen der Deutschen Gesellschaft für Pathologie 1994;78():26-33.
1993: Barker P E; Savelyeva L; Schwab M
Translocation junctions cluster at the distal short arm of chromosome 1 (1p36.1-2) in human neuroblastoma cells.
Oncogene 1993;8(12):3353-8.
1993: Cziepluch C; Wenzel A; Schürmann J; Schwab M
Activation of gene transcription by the amino terminus of the N-Myc protein does not require association with the protein encoded by the retinoblastoma suppressor gene RB1.
Oncogene 1993;8(10):2833-8.
1993: Schwab M
Genes, chromosomes and cancer. First meeting of the "Arbeitsgemeinschaft Molekular- und Zytogenetik (AEK)" of the Deutsche Krebsgesellschaft.
Journal of cancer research and clinical oncology 1993;119(7):434-8.
1992: Schwab M
Molecular cytogenetics of human neuroblastoma.
Biochimica et biophysica acta 1992;1114(1):43-50.
1992: van der Bosch K; Becker I; Savelyeva L; Brüderlein S; Schlag P; Schwab M
Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines.
Genes, chromosomes & cancer 1992;5(1):91-5.
1992: Amler L C; Shibasaki Y; Savelyeva L; Schwab M
Amplification of the N-myc gene in human neuroblastomas: tandemly repeated amplicons within homogeneously staining regions on different chromosomes with the retention of single copy gene at the resident site.
Mutation research 1992;276(3):291-7.
1992: Amler L C; Schwab M
Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA.
Oncogene 1992;7(4):807-9.
1991: Wenzel A; Cziepluch C; Hamann U; Schürmann J; Schwab M
The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells.
The EMBO journal 1991;10(12):3703-12.
1991: Hamann U; Wenzel A; Frank R; Schwab M
The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367.
Oncogene 1991;6(10):1745-51.
1991: Zink D; Weith A; Martinsson T; Schwab M
Analysis of chromosome band 1p36 alterations by chromosomal in situ suppression hybridization with a microclone DNA bank.
Genes, chromosomes & cancer 1991;3(5):407-10.
1991: Hiller S; Breit S; Wang Z Q; Wagner E F; Schwab M
Localization of regulatory elements controlling human MYCN expression.
Oncogene 1991;6(6):969-77.
1991: Schwab M
Is there a neuroblastoma anti-oncogene?
Progress in clinical and biological research 1991;366():1-9.
1991: Schwab M
Enhanced expression of the cellular oncogene MYCN and progression of human neuroblastoma.
Advances in enzyme regulation 1991;31():329-38.
1990: Leister I; Weith A; Brüderlein S; Cziepluch C; Kangwanpong D; Schlag P; Schwab M
Human colorectal cancer: high frequency of deletions at chromosome 1p35.
Cancer research 1990;50(22):7232-5.
1990: Schwab M
Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas.
Brain pathology (Zurich, Switzerland) 1990;1(1):41-6.
1990: Schweigerer L; Breit S; Wenzel A; Tsunamoto K; Ludwig R; Schwab M
Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity.
Cancer research 1990;50(14):4411-6.
1990: Schwab M
[Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration]
Klinische Pädiatrie 1990;202(4):197-201.
1990: Brüderlein S; van der Bosch K; Schlag P; Schwab M
Cytogenetics and DNA amplification in colorectal cancers.
Genes, chromosomes & cancer 1990;2(1):63-70.
1990: Schwab M; Amler L C
Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer.
Genes, chromosomes & cancer 1990;1(3):181-93.
1990: Schwab M
Oncogene amplification in neoplastic development and progression of human cancers.
Critical reviews in oncogenesis 1990;2(1):35-51.
1989: Amler L C; Schwab M
Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA.
Molecular and cellular biology 1989;9(11):4903-13.
1989: Weith A; Martinsson T; Cziepluch C; Brüderlein S; Amler L C; Berthold F; Schwab M
Neuroblastoma consensus deletion maps to 1p36.1-2.
Genes, chromosomes & cancer 1989;1(2):159-66.
1989: Breit S; Schwab M
Suppression of MYC by high expression of NMYC in human neuroblastoma cells.
Journal of neuroscience research 1989;24(1):21-8.
1989: Martinsson T; Weith A; Cziepluch C; Schwab M
Chromosome 1 deletions in human neuroblastomas: generation and fine mapping of microclones from the distal 1p region.
Genes, chromosomes & cancer 1989;1(1):67-78.
1989: Schwab M
Genetic principles of tumor suppression.
Biochimica et biophysica acta 1989;989(1):49-64.
1989: Schwab M; Oehlmann R; Brüderlein S; Wakamatsu Y
Amplified DNA in cells of genetic melanoma of Xiphophorus.
Oncogene 1989;4(2):139-44.
1989: Schwab M
Suppression of genetic melanoma in the fish Xiphophorus.
Ciba Foundation symposium 1989;142():181-97; discussion 197-8.
1989: Schwab M
Genetic suppression of malignancy.
IARC scientific publications 1989;(96):239-54.
1988: Schwab M; Bishop J M
Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9585-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Manfred Schwab

Research Profile (preview)

Disorders

Physiology

Genes & Molecular Sequences

Anatomy

Procedures

Chemicals & Drugs

Living Beings

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Manfred Schwab (preview)

All Publications